Drug intelligence / Profile preview

Pulmo-LS

Development stage
Unknown
Lead developer
Anglo-French Drugs & Industries
Modality
Small Molecules
Administration
Oral
01

Overview

Pulmo-LS is an oral expectorant and mucolytic combination syrup developed and marketed by Anglo-French Drugs & Industries for the treatment of productive cough associated with asthma, bronchitis, and respiratory tract infections. It is a fixed-dose combination containing three active ingredients: ambroxol, a mucolytic agent that thins and loosens mucus; guaifenesin, an expectorant that increases respiratory tract fluid to reduce mucus stickiness; and levosalbutamol (also known as levalbuterol), a beta-2 adrenergic receptor agonist that acts as a bronchodilator to relax airway smooth muscles and facilitate easier breathing.

Brand names
AFD-PULMO-LSPULMO –LS SyrupPulmo-LSPulmo-LS PDPulmo-LS Syrup
Other names
ambroxol + guaifenesin + levosalbutamolambroxol hydrochloride + guaifenesin + levosalbutamol sulfateguaifenesin + levosalbutamol + ambroxollevosalbutamol + ambroxol + guaifenesin
02

Targets

ADRB2 (β2)GBA2 (Beta-glucosidase 2)

Beyond the preview

Go deeper on Pulmo-LS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmo-LS.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call